Also found in: Medical, Encyclopedia.
Related to neuromyelitis: neuromyelitis optica


n. neuromielitis, infl. de los nervios de la espina dorsal.
References in periodicals archive ?
Neuromyelitis optica spectrum disease (NMOSD) refers to a group of related disease, in which potential pathogenesis is similar to neuromyelitis optica (NMO), but clinical involvement does not exactly correspond to the diagnosis of NMO.
Net proceeds will be used by the company for the ongoing Abili-T clinical study of Tcelna for secondary progressive MS, the preclinical and manufacturing activities for OPX-212 for neuromyelitis optica (NMO), general corporate purposes, working capital, research and development, business development as well as operational purposes.
ON is an immune-mediated inflammation of the optic nerve, which could be the initiated symptom of multiple sclerosis (MS) or neuromyelitis optica (NMO).
The second topic of the morning session dealt with the controversy about whether neuromyelitis optica (NMO) is a distinct disease entity from MS with B Weinshenker (USA) arguing the affirmative and A Compston (UK) arguing the negative.
Background: Neuromyelitis optica (NMO) and multiple sclerosis (MS) are demyelinating disorders of the central nervous system.
The discovery of a specific autoantibody response in neuromyelitis optica (NMO) patients, which selectively targets astrocytic end feet at the glia limitans (1) and which is directed against the water channel aquaporin-4 (AQP-4) (2) was a milestone in defining this disease entity and profoundly changed our view regarding its pathogenesis.
18] found the association between autophagy-related gene 5 ( ATG5 ) and neuromyelitis optica, but failed in MS.
This includes inebilizumab, currently in Phase II trial development for the treatment of neuromyelitis optica, a rare condition that affects the optic nerve and spinal cord in approximately five in 100,000 people.
Inebilzumab is being evaluated for the treatment of neuromyelitis optica, a rare condition affecting the optic nerve and spinal cord.
This will include inebilizumab which is currently in Phase II trial development for the treatment of neuromyelitis optica.
It has been found that cetirizine - common allergy medication - is safe, well-tolerated, and may reduce relapses in patients with neuromyelitis optica (NMO).
Neuromyelitis optica spectrum disorder (NMOSD) is a chronic autoimmune demyelinating disease of the CNS, usually of the optic nerve and spinal cord, that is associated with serum anti-aquaporin-4 (AQP4) immunoglobulin G antibodies, which have a sensitivity of 60~70% and specificity of 99% for the disease.
Full browser ?